5 stories to read for Depression Awareness Month

More than 17 million adults in the U.S. have experienced a major depressive episode, according to data from the 2017 National Survey on Drug Use and Health.

Depression is a treatable condition, but no two people are affected the same way and there is no “one-size-fits-all” treatment. To highlight Depression Awareness Month this October, Healio Psychiatry has compiled a list of stories from the last year featuring the latest research for psychiatrists and other mental health professionals.

Physical activity protects against depression

Robust evidence supports a protective relationship between objectively assessed physical activity and major depression risk, according to findings from a two-sample mendelian randomization study. Read more.

Next-generation antidepressants show promise for treatment-resistant disease

SAN FRANCISCO — In a session here, experts discussed advances in the understanding and treatment of treatment-resistant depression. Read more.

FDA approves esketamine nasal spray for hard-to-treat depression

The FDA has approved esketamine nasal spray, combined with an oral antidepressant, for the treatment of adults with treatment-resistant depression, according to a press release. Read more.

Clinicians guide to anti-inflammatory treatments for major depression

Targeting inflammation is a promising way to treat patients with major depressive disorder, according to a report in Journal of Clinical Psychiatry. Read more.

Anti-inflammatory agents improve antidepressant effects

Certain anti-inflammatory drugs improved antidepressant treatment effects and depression symptoms without increasing risk for adverse events, according to findings from a systematic review and meta-analysis. Read more.